Clinical implications of telomerase in cancer

European Journal of Cancer Part A

Volumn 33, Issue 5, 1997, Pages 781-786

  Kim, N W ^a  

^a GERON CORPORATION   (United States)

Author keywords

cancer therapy; diagnosis; prognosis; telomerase; telomeres

Indexed keywords

TELOMERASE;

ARTICLE; CANCER THERAPY; CARCINOGENESIS; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL PROLIFERATION; ENZYME INDUCTION; GENE TARGETING; HUMAN; PRIORITY JOURNAL; TELOMERE;

CELL AGING; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; PROGNOSIS; TELOMERASE; TELOMERE;

EID: 0030923688     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00057-9     Document Type: Article

References (35)

1. Weinberg RA. Oncogenes, antioncogenes, and the molecular basis of multistep carcinogenesis. Cancer Res 1989, 49, 3713-3721.
2. Stamps AC, Gusterson BA, O'Hare MJ. Are tumours immortal? Eur J Cancer 1992, 28A, 1495-1499.
3. Harley CB, Kim NW. Telomerase and cancer. In De Vita VT, Hellman S, Rosenberg SA eds. Important Advances in Oncology 1996. Philadelphia, Lippincott-Raven Publishers, 1996, 57-67.
4. Counter CM, Botelho FM, Wang P, Harley CB, Bacchetti S. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes. J Virol 1994, 68, 3410-3414.
5. Counter CM, Hirte HW, Baccetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 1994, 91, 2900-2904.
6. Harley CB, Villeponteau B. Telomeres and telomerase in aging and cancer. Curr Opin Genet Dev 1995, 5, 249-255.
7. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266, 2011-2015.
8. McClintock B. The stability of broken ends of chromosomes in Zea mays. Genetics 1941, 41, 234-282.
9. Albanell J, Han W, Mellado B, et al. Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines. Cancer Res 1996, 56, 1503-1508.
10. Chiu CP, Dragowska W, Kim NW, et al. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 1996, 14, 239-248.
11. Shay JW, Wright WE. Telomerase activity in human cancer. Curr Opin Oncol 1996, 8, 66-71.
12. Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science 1995, 269, 1236-1241.
13. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity-levels with human neuroblastoma outcomes. Nat Med 1995, 1, 249-255.
14. Harley CB, Kim NW, Prowse KR, et al. Telomerase, cell immortality, and cancer. Cold Spring Harbor Symp Quant Biol 1994, LIX, 307-315.
15. Hiyama K, Ishioka S, Shirotani Y, et al. Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and Rb. Oncogens 1995, 10, 937-944.
16. Hiyama E, Yokoyama T, Tatsumoto N, et al. Telomerase activity in gastric cancer. Cancer Res 1995, 55, 3258-3262.
17. Bodnar AG, Kim NW, Effros RB, Chiu C-P. Mechanism of telomerase induction during T cell activation. Exp Cell Res 1996, 228, 58-64.
18. Broccoli D, Young JW, de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995, 92, 9082-9086.
19. Hiyama K, Hirai Y, Kyoizumi S, et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995, 155, 3711-3715.
20. Tahara H, Nakanishi T, Kitamoto M, et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995, 55, 2734-2736.
21. Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA, Shay JW. Detection of telomerase activity in malignant and nonmalignant skin conditions. J Invest Dermatol 1996, 106, 759-765.
22. Weng NP, Levine BL, June CH, Hodes RJ. Regulated expression of telomerase activity in human T lymphocyte development and activation. J Exp Med 1996, 183, 2471-2479.
23. Vaziri H, Schachter F, Uchida I, et al. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Human Genet 1993, 52, 661-667.
24. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994, 91, 9857-9860.
25. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990, 346, 866-868.
26. Lindsey J, McGill N, Lindsey L, Green D, Cooke H. In vivo loss of telomeric repeats with age in humans. Mutat Res 1991, 256, 45-48.
27. Tahara E, Semba S, Tahara H. Molecular biological observations in gastric cancer. Semin Oncol 1996, 23, 307-315.
28. Piatyszek MA, Kim NW, Weinrich SL, et al. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Meth Cell Science 1995, 17, 1-15.
29. Kim NW. Assay method for the telomeric repeat amplification protocol (TRAP). Retinoids Today and Tomorrow 1995, 40, 40-43.
30. Morin GB. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989, 59, 521-529.
31. Greider C, Blackburn E. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985, 43, 405-413.
32. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 1996, 56, 645-650.
33. Blasco MA, Funk W, Villeponteau B, Greider CW. Functional characterization and developmental regulation of mouse telomerase RNA. Science 1995, 269, 1267-1270.
34. Chang E, Harley CB. Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA 1995, 92, 11190-11194.
35. Effros RB, Allsopp R, Chiu C-P, et al. Shortened telomeres in the expanded CD28 - CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 1996, 10, F17-F22.